小智港股覆盤 | 3月18日
今日,港股三大指數集體下跌。截止收盤,恆生指數跌0.41%,報21412點。國企指數跌0.56%,報7366點。恆生科技指數跌1.92%,報4484點。市場約1032只個股上漲,710只個股下跌。成交額突破2366.84億港幣,和昨天同期相比下跌21.36%。南下資金淨流入28.24億港幣。

盤面上,化學制品板塊集體拉昇。深藍科技控股漲超12%;中國心連心化肥、中海石油化學等多股漲超11%;華寶國際、東嶽集團等多股漲超6%。深藍科技控股擬3月29日舉行董事會會議審覈年度業績;中國心連心化肥3月25日舉行董事會會議審批年度業績;化肥股整體活躍,中海石油化學升8%,機構指3月下旬尿素基本面或改善;華寶國際3月25日舉行董事會會議審批年度業績。

造紙林業板塊大漲靠前。玖龍紙業漲超6%;綠心集團漲超5%。

餐飲酒店板塊漲幅較前。龍輝國際控股漲超17%;奧克斯國際漲超13%;海昌海洋公園、非凡中國等多股漲超11%;佳民集團漲超10%。龍輝國際控股3月30日舉行董事會會議審批年度業績;海昌海洋公園續升9%,年度淨利預計不少於8.3億元,天風首評給予“買入”;非凡中國(8032.HK)績前搶跑,續升超10%,市值重回百億港元。

CRO板塊多數下跌。金斯瑞生物科技跌超6%;藥明生物跌超5%;康龍化成跌超4%;藥明康德跌超2%;中國醫療集團跌超1%。大和升藥明生物評級至「買入」,目標價下調至72元;康龍化成3月25日董事會審議及批準年度業績。

菸草板塊跌幅居前。思摩爾國際跌超3%。中金:維持思摩爾國際,“跑贏行業”評級,目標價降36%至32港元。

uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.